Get a clearer picture of your investigational drug prior to market launch
Interestingly, the pharmaceutical industry has remained one of the few industries where direct user feedback is not an active part of the product development process.
When developing new drugs there has been a strong tradition of only asking pre-specified questions to the patients testing a new drug in clinical trials. Yet, only using pre-specified questions to examine an investigational drug with an unclear product profile, it can be difficult to ensure that what is measured is complete and relevant to the patients. Additionally, it can be hard to obtain sufficient knowledge on what the patients think about the drug, how the drug impacts their daily lives, and what matters the most to them when using the drug.
To overcome this uncertainty, interviewing patients who participate in clinical trials is beneficial in terms of ensuring that all relevant user feedback is captured and documented before an investigational drug is released into market.
The feedback from patient interviews can help examine what patients think of an investigational drug, which can provide valuable input to answer important marketing questions, including:
- How do the patients value the attributes of the investigational drug?
- How do the patients view the value propositions of the investigational drug?
- How do the patients compare the investigational drug to existing treatments?
Knowing the answers to these questions will also enable you to develop a more clear and relevant communication around the new drug, and better target the marketing efforts towards individuals for whom the drug will matter the most.
Would you like to hear what users think of your investigational drug?
At Clinigma®, we recommend interviewing the users who are exposed to an investigational drug as early as possible in the trial program. In this way you can minimize the risk of overlooking important patient feedback, and at the same time get a better understanding of how the patients experience and value the effects of your investigational drug.
Clinigma® provides expert solutions in capturing patient feedback in clinical trials in accordance with regulatory requirements. With the largest global network of researchers on the market, we are able to interview patients worldwide, which enables us to accommodate the needs of global pharmaceutical companies.
The qualitative researchers at Clinigma® are highly educated within anthropology, psychology, sociology or similar fields and have undergone GCP and other relevant training to ensure that the interview questions posed to patients and healthcare professionals are appropriate and relevant.
Click here to read more about our expertise in the field of patient interviews.
